These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 23327881
1. Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice. Tanaka H, Watanabe S, Aizawa-Yashiro T, Oki E, Kumagai N, Tsuruga K, Ito E. Nephron Clin Pract; 2012; 121(3-4):c165-73. PubMed ID: 23327881 [Abstract] [Full Text] [Related]
2. Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose. Tanaka H, Oki E, Tsuruga K, Yashiro T, Hanada I, Ito E. Clin Nephrol; 2009 Dec; 72(6):430-6. PubMed ID: 19954719 [Abstract] [Full Text] [Related]
3. Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study. Tanaka H, Oki E, Tsugawa K, Nonaka K, Suzuki K, Ito E. Lupus; 2007 Dec; 16(11):896-900. PubMed ID: 17971363 [Abstract] [Full Text] [Related]
4. Mizoribine treatment of young patients with severe lupus nephritis: a clinicopathologic study by the tohoku pediatric study group. Tanaka H, Oki E, Tsuruga K, Sato N, Matsukura H, Matsunaga A, Kondo Y, Suzuki J. Nephron Clin Pract; 2008 Dec; 110(2):c73-9. PubMed ID: 18758186 [Abstract] [Full Text] [Related]
5. Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis. Tanaka H, Aizawa T, Watanabe S, Oki E, Tsuruga K, Imaizumi T. Lupus; 2014 Jul; 23(8):813-8. PubMed ID: 24651669 [Abstract] [Full Text] [Related]
6. Clinical assessment of tacrolimus therapy in lupus nephritis: one-year follow-up study in a single center. Asamiya Y, Uchida K, Otsubo S, Takei T, Nitta K. Nephron Clin Pract; 2009 Jul; 113(4):c330-6. PubMed ID: 19729969 [Abstract] [Full Text] [Related]
7. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis. Tanaka H, Tsugawa K, Suzuki K, Nakahata T, Ito E. Pediatr Nephrol; 2006 Jul; 21(7):962-6. PubMed ID: 16773408 [Abstract] [Full Text] [Related]
8. Mizoribine for the treatment of lupus nephritis in children and adolescents. Tanaka H, Tsugawa K, Tsuruga K, Suzuki K, Nakahata T, Ito E, Waga S. Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899 [Abstract] [Full Text] [Related]
9. Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study. Mok CC, To CH, Yu KL, Ho LY. Lupus; 2013 Oct; 22(11):1135-41. PubMed ID: 23995863 [Abstract] [Full Text] [Related]
10. Tacrolimus versus cyclophosphamide as treatment for diffuse proliferative or membranous lupus nephritis: a non-randomized prospective cohort study. Wang S, Li X, Qu L, Wang R, Chen Y, Li Q, He X, Zhang X, Wang H, Wu J, Xu Y, Chen J. Lupus; 2012 Aug; 21(9):1025-35. PubMed ID: 22570338 [Abstract] [Full Text] [Related]
11. Long-term data on tacrolimus treatment in lupus nephritis. Yap DY, Ma MK, Mok MM, Kwan LP, Chan GC, Chan TM. Rheumatology (Oxford); 2014 Dec; 53(12):2232-7. PubMed ID: 24996908 [Abstract] [Full Text] [Related]
12. Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients. Tanaka H, Tsugawa K, Oki E, Suzuki K, Ito E. Clin Rheumatol; 2008 Jan; 27(1):85-9. PubMed ID: 17483980 [Abstract] [Full Text] [Related]
13. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis]. Cai XY, Yang XY, Chen XH, Liang LQ, Guan MM, Qin SG, Fu JZ. Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1436-9. PubMed ID: 15500738 [Abstract] [Full Text] [Related]
14. Tacrolimus is effective for lupus nephritis patients with persistent proteinuria. Uchino A, Tsukamoto H, Nakashima H, Yoshizawa S, Furugo I, Mitoma H, Oryoji K, Shimoda T, Niiro H, Tada Y, Yano T, Nonaka T, Oishi R, Akashi K, Horiuchi T. Clin Exp Rheumatol; 2010 Sep 02; 28(1):6-12. PubMed ID: 20346231 [Abstract] [Full Text] [Related]
15. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children. Tangnararatchakit K, Tapaneya-Olarn C, Tapaneya-Olarn W. J Med Assoc Thai; 1999 Nov 02; 82 Suppl 1():S104-10. PubMed ID: 10730528 [Abstract] [Full Text] [Related]
16. Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study. Mok CC, Tong KH, To CH, Siu YP, Au TC. Kidney Int; 2005 Aug 02; 68(2):813-7. PubMed ID: 16014060 [Abstract] [Full Text] [Related]
17. Low-dose tacrolimus in treating lupus nephritis refractory to cyclophosphamide: a prospective cohort study. Fei Y, Wu Q, Zhang W, Chen H, Hou Y, Xu D, Li M, Zhang X, Zhao Y, Zeng X, Zhang F. Clin Exp Rheumatol; 2013 Aug 02; 31(1):62-8. PubMed ID: 22935463 [Abstract] [Full Text] [Related]
18. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ]. Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S. Srp Arh Celok Lek; 2002 Aug 02; 130 Suppl 3():19-25. PubMed ID: 12583309 [Abstract] [Full Text] [Related]
19. Long-term effects of tacrolimus for maintenance therapy of lupus nephritis: a 5-year retrospective study at a single center. Karasawa K, Uchida K, Kodama M, Moriyama T, Nitta K. Rheumatol Int; 2018 Dec 02; 38(12):2271-2277. PubMed ID: 30203113 [Abstract] [Full Text] [Related]
20. Efficacy and safety of tacrolimus for induction therapy in patients with active lupus nephritis. Takahashi S, Hiromura K, Sakurai N, Matsumoto T, Ikeuchi H, Maeshima A, Kaneko Y, Kuroiwa T, Nojima Y. Mod Rheumatol; 2011 Jun 02; 21(3):282-9. PubMed ID: 21188448 [Abstract] [Full Text] [Related] Page: [Next] [New Search]